NERRE THERAPEUTICS

Updated 46 days ago
Private Limited Company
  • Active - 07916206 (CH)
  • Age: 12 years
  • ID: 31193114/94
STEVENAGE BIOSCIENCE CATALYST INCUBATOR BUILDING GUNNELS WOOD ROAD STEVENAGE HERTFORDSHIRE SG1 2FX
CLICK HERE TO SEE DETAILS OF COMPANY CHANGES
• 72110 - Research and experimental development on biotechnology
NeRRe Therapeutics is a clinical-stage company developing the neurokinin(NK)-1 receptor antagonist orvepitant for the treatment of common, chronic, and debilitating conditions caused by neural hypersensitivity associated with Substance P/ NK-1 receptor system dysfunction... NeRRe Therapeutics is a UK based clinical-stage company developing a unique portfolio of neurokinin (NK) receptor antagonists for the treatment of common debilitating conditions caused by neuronal hypersensitivity.
Also known as: NeRRe, NeRRe Therapeutics Limited, NERRE THERAPEUTICS LTD
Previous names: MOFO FIFTY-ONE LIMITED
Registration numbers: 07916206 (CH)
Primary location: STEVENAGE
Associated domains: ipf-comfort-study.com
  • 0
  • 0
Interest Score
1
HIT Score
0.60
CEO
Dr Mary Kerr
CFO
Rebecca Hemsley
Chairman
Andrew Kay, Dr Iain Dukes, Iain D Dukes
Founder
Dr Mike Trower
SVP
Jo Craig
General
in..@nerretherapeutics.com, in..@nerretherapeutics.com

UK Company Data

Company number
07916206		 Account category
FULL		 Account ref. day
30		 Account ref. month
6
Accounts next due date
2025-03-31		 Accounts last made up date
2023-06-30		 Returns next due date
2017-03-15		 Returns last made up date
2016-02-15
Num. mort. charges
0		 Num. mort. outstanding
0		 Num. mort. part. satisfied
0		 Num. mort. satisfied
0
Num. gen. partners
0		 Num. lim. partners
0
Domain
nerretherapeutics.com
Actual
www.nerretherapeutics.com
IP
160.153.133.159
Status
OK
Category
Company
0 comments Add a comment